Figure 1.
Shares (%) of studied insulin-like growth factor-1 mRNA isoforms of class 1 (I) and class 2 (II) (depending upon employed promoter P1 or P2) as related to the total mRNA for both insulin-like growth factor-1 promoters (100%) in chronic hepatitis C patients and in the control. IGF: Insulin-like growth factor; CH-C: Chronic hepatitis C.